Workflow GuideChronic Kidney Disease

CKD Chronic Care Risk Stratification Workflow Guide

Optimize Chronic Kidney Disease outcomes with our CKD risk stratification workflow, focusing on eGFR monitoring, APCM enrollment, and AI-driven care.

Effective risk stratification in Chronic Kidney Disease (CKD) is essential for slowing progression and delaying dialysis. This workflow guides practices through identifying high-risk patients based on eGFR, albuminuria, and comorbidities, ensuring timely interventions and APCM enrollment.

The Challenge

Many CKD patients are not identified for advanced care until they reach Stage 4 or 5. Manual monitoring of lab results is prone to error, leading to missed opportunities for medication adjustments and early transplant or dialysis preparation.

Step-by-Step Workflow

1

Baseline eGFR and UACR Assessment

Establish a diagnostic baseline by aggregating historical lab data. AI can scan EHR records to flag patients with a significant decline in renal function over a 6-month period, prioritizing those needing immediate nephrology review.

Best Practices
  • Use the CKD-EPI 2021 equation for eGFR calculation
  • Standardize lab collection times to reduce variability
Common Pitfalls
  • Relying solely on serum creatinine without calculating eGFR
2

Comorbidity and Risk Factor Audit

Identify patients with diabetes and hypertension, the leading causes of CKD. Review blood pressure targets and A1c levels to ensure they meet KDIGO standards for renal protection and cardiovascular health.

Best Practices
  • Screen for SGLT2 inhibitor eligibility in diabetic patients
  • Check for presence of proteinuria at every visit
Common Pitfalls
  • Ignoring albuminuria in patients with controlled blood pressure
3

APCM Enrollment and Tiering

Categorize patients into risk tiers based on their stage of CKD and rate of progression. Enroll Stage 3b-5 patients into Advanced Primary Care Management (APCM) for high-touch oversight and care coordination.

Best Practices
  • Use specific G-codes for billing compliance
  • Assign a dedicated renal care manager to high-risk tiers
Common Pitfalls
  • Waiting until Stage 4 to initiate chronic care management protocols
4

AI-Powered Lab Compliance Outreach

Deploy AI-powered call handling to automate reminders for blood work and urinalysis. This ensures that eGFR and electrolyte levels are monitored consistently without increasing the administrative burden on office staff.

Best Practices
  • Personalize reminders using AI voice technology
  • Track missed lab appointments automatically via integrated dashboards
Common Pitfalls
  • Using manual calling which leads to low compliance and staff burnout
5

Renal Nutrition and Education

Provide stage-specific education on managing protein, potassium, and phosphorus intake. Early dietary intervention is critical for managing metabolic bone disease and anemia in advanced CKD stages.

Best Practices
  • Refer to a renal dietitian early in the disease process
  • Provide easy-to-read potassium and sodium guides
Common Pitfalls
  • Offering generic diet advice not tailored to the specific CKD stage
6

Medication Safety and Dose Adjustments

Regularly review medication lists to avoid nephrotoxic agents like NSAIDs. Adjust dosages for medications cleared by the kidneys to prevent toxicity as eGFR declines, focusing on anticoagulants and antibiotics.

Best Practices
  • Use a clinical pharmacist for quarterly medication reviews
  • Update EMR alerts for renal dosing based on latest eGFR
Common Pitfalls
  • Overlooking over-the-counter NSAID use by the patient
7

Advanced Transition Planning

For patients approaching Stage 5, initiate transplant evaluations and vascular access surgery discussions. Early planning prevents emergency dialysis starts via catheters and improves long-term survival rates.

Best Practices
  • Coordinate with transplant centers during Stage 4
  • Discuss home dialysis options before the patient reaches ESRD
Common Pitfalls
  • Starting dialysis via central venous catheter instead of a mature fistula

Expected Outcomes

1

Significant reduction in the rate of eGFR decline

2

Increased practice revenue through APCM and CCM enrollment

3

Improved patient compliance with monthly lab monitoring

4

Reduction in emergency dialysis starts (crashing onto dialysis)

5

Enhanced patient satisfaction through proactive AI communication

Frequently Asked Questions

AI can analyze large datasets from EHRs to identify trends in eGFR decline that manual review might miss, and automate outreach to ensure lab compliance.

The Urine Albumin-to-Creatinine Ratio (UACR) provides a measure of kidney damage that, when combined with eGFR, offers a more accurate prediction of progression risk.

Yes, AI can be programmed to deliver specific educational modules, such as dietary tips or medication reminders, ensuring consistent patient support between visits.

Ready to transform your chronic kidney disease practice?

See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.

Schedule a Demo
CKD Chronic Care Risk Stratification Workflow Guide | Tile Health